These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 17649779)

  • 1. Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer.
    Zieglschmid V; Hollmann C; Mannel J; Albert W; Jaeschke-Melli S; Eckstein B; Hillemann T; Greten TF; Gross E; Böcher O
    Anticancer Res; 2007; 27(4A):1823-32. PubMed ID: 17649779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients.
    Shimada R; Iinuma H; Akahane T; Horiuchi A; Watanabe T
    Oncol Rep; 2012 Apr; 27(4):947-53. PubMed ID: 22267181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous expression of tumor-associated genes in disseminated breast cancer cells.
    Zieglschmid V; Hollmann C; Gutierrez B; Krehan A; Kaul S; Böcher O
    Anticancer Res; 2007; 27(4A):1769-76. PubMed ID: 17649771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.
    Pesta M; Fichtl J; Kulda V; Topolcan O; Treska V
    Anticancer Res; 2013 May; 33(5):2239-43. PubMed ID: 23645782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR for CEA and CK20 mRNAS.
    Oberg AN; Lindmark GE; Israelsson AC; Hammarström SG; Hammarström ML
    Int J Cancer; 2004 Aug; 111(1):101-10. PubMed ID: 15185350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
    Wang JY; Wu CH; Lu CY; Hsieh JS; Wu DC; Huang SY; Lin SR
    World J Surg; 2006 Jun; 30(6):1007-13. PubMed ID: 16736329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of carcinoembryonic antigen (CEA), epidermal growth factor receptor (EGFR), epithelial cell adhesion molecule EpCAM (GA733-2), and carbohydrate antigen 19-9 (CA 19-9) levels in colorectal cancer patients and correlation with clinicopathological characteristics.
    Mourtzikou A; Stamouli M; Kroupis C; Christodoulou S; Skondra M; Kastania A; Pectasides D; Athanasas G; Dimas C
    Clin Lab; 2012; 58(5-6):441-8. PubMed ID: 22783573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of the Serum Level of Carcinoembryonic Antigen and Prolactin with Different Stages of Colorectal Carcinoma According to Dukes' Staging.
    Rahman MR; Sheikh SH; Lima IJ; Islam MR; Faisal M; Islam MS; Faruk MO; Jalal MT
    Mymensingh Med J; 2016 Jan; 25(1):61-5. PubMed ID: 26931251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer.
    Carpelan-Holmström M; Haglund C; Lundin J; Järvinen H; Roberts P
    Eur J Cancer; 1996 Jun; 32A(7):1156-61. PubMed ID: 8758246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of positive and negative immunomagnetic isolation followed by real-time RT-PCR for detection of the circulating tumor cells in patients with colorectal cancers.
    Guo J; Xiao B; Zhang X; Jin Z; Chen J; Qin L; Mao X; Shen G; Chen H; Liu Z
    J Mol Med (Berl); 2004 Nov; 82(11):768-74. PubMed ID: 15490093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time PCR (TaqMan PCR) quantification of carcinoembryonic antigen (CEA) mRNA in the peripheral blood of colorectal cancer patients.
    Miura M; Ichikawa Y; Tanaka K; Kamiyama M; Hamaguchi Y; Ishikawa T; Yamaguchi S; Togo S; Ike H; Ooki S; Shimada H
    Anticancer Res; 2003; 23(2B):1271-6. PubMed ID: 12820382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay.
    De Luca A; Pignata S; Casamassimi A; D'Antonio A; Gridelli C; Rossi A; Cremona F; Parisi V; De Matteis A; Normanno N
    Clin Cancer Res; 2000 Apr; 6(4):1439-44. PubMed ID: 10778975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of CTCs in tumor drainage vein blood as a biomarker for prognosis in colorectal cancer patients with Dukes' stage B and C].
    Shimada R; Iinuma H; Tamura J; Horiuchi A; Nozawa K; Ishihara S; Matsuda K; Watanabe T; Hashiguchi Y
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1763-5. PubMed ID: 23267879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
    Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
    Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer.
    Guller U; Zajac P; Schnider A; Bösch B; Vorburger S; Zuber M; Spagnoli GC; Oertli D; Maurer R; Metzger U; Harder F; Heberer M; Marti WR
    Ann Surg; 2002 Dec; 236(6):768-75; discussion 775-6. PubMed ID: 12454515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer.
    Louhimo J; Carpelan-Holmström M; Alfthan H; Stenman UH; Järvinen HJ; Haglund C
    Int J Cancer; 2002 Oct; 101(6):545-8. PubMed ID: 12237895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.